X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18143) 18143
Publication (943) 943
Conference Proceeding (185) 185
Dissertation (139) 139
Book Chapter (64) 64
Newspaper Article (50) 50
Book Review (44) 44
Magazine Article (13) 13
Government Document (8) 8
Book / eBook (5) 5
Paper (5) 5
Newsletter (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
carbazole (4782) 4782
humans (4167) 4167
carbazoles - pharmacology (3919) 3919
animals (3903) 3903
carbazoles (3382) 3382
index medicus (3309) 3309
male (2805) 2805
carbazoles - therapeutic use (2078) 2078
female (1956) 1956
derivatives (1851) 1851
chemistry, multidisciplinary (1799) 1799
rats (1635) 1635
chemistry, organic (1575) 1575
carbazoles - chemistry (1533) 1533
propanolamines - therapeutic use (1436) 1436
carbazol (1382) 1382
pharmacology & pharmacy (1364) 1364
carvedilol (1362) 1362
materials science, multidisciplinary (1348) 1348
fluorescence (1192) 1192
polymers (1181) 1181
carbazole derivatives (1168) 1168
polymer science (1118) 1118
mice (1117) 1117
adrenergic beta-antagonists - therapeutic use (1104) 1104
middle aged (1091) 1091
enzyme inhibitors - pharmacology (1087) 1087
analysis (1028) 1028
biochemistry & molecular biology (1027) 1027
devices (951) 951
indoles - pharmacology (933) 933
light-emitting-diodes (906) 906
chemistry, physical (886) 886
carbazoles - administration & dosage (869) 869
dose-response relationship, drug (857) 857
propanolamines - pharmacology (808) 808
cardiac & cardiovascular systems (804) 804
adult (796) 796
molecular structure (786) 786
heart failure - drug therapy (761) 761
aged (753) 753
physics, applied (714) 714
chemistry (705) 705
electroluminescence (701) 701
chemistry, medicinal (695) 695
cells, cultured (689) 689
synthesis (656) 656
indoles (628) 628
conjugated polymers (623) 623
treatment outcome (622) 622
carbazoles - chemical synthesis (618) 618
protein kinase c - antagonists & inhibitors (601) 601
emission (596) 596
neurosciences (594) 594
chemistry, applied (583) 583
phosphorylation (583) 583
time factors (577) 577
alkaloids (574) 574
catalysis (557) 557
activation (547) 547
copolymers (531) 531
engineering, chemical (531) 531
propanolamines - administration & dosage (521) 521
adrenergic beta-antagonists - pharmacology (520) 520
carbazoles - metabolism (520) 520
rats, sprague-dawley (520) 520
indole alkaloids (508) 508
design (505) 505
efficiency (503) 503
performance (491) 491
expression (483) 483
polymerization (481) 481
photoluminescence (479) 479
heart failure (477) 477
polyvinyl carbazole (465) 465
ligands (463) 463
cell line, tumor (462) 462
research (462) 462
light-emitting diodes (457) 457
cell biology (455) 455
poly (453) 453
polymer (453) 453
diodes (438) 438
in vitro techniques (438) 438
carbazole alkaloids (436) 436
kinetics (436) 436
solar cells (429) 429
carbazoles - adverse effects (428) 428
organic chemistry (426) 426
physics, condensed matter (426) 426
pyrroles - pharmacology (419) 419
organic light emitting diodes (409) 409
apoptosis (406) 406
structure-activity relationship (406) 406
photovoltaic cells (401) 401
alkaloids - pharmacology (399) 399
chemical properties (399) 399
signal transduction (394) 394
electrochemistry (393) 393
oncology (390) 390
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17731) 17731
Japanese (370) 370
Chinese (305) 305
Russian (133) 133
German (132) 132
French (77) 77
Korean (51) 51
Italian (21) 21
Spanish (19) 19
Polish (17) 17
Czech (9) 9
Turkish (8) 8
Hungarian (7) 7
Portuguese (6) 6
Ukrainian (6) 6
Danish (4) 4
Dutch (2) 2
Norwegian (2) 2
Swedish (2) 2
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bioorganic and Medicinal Chemistry Letters, ISSN 0960-894X, 01/2013, Volume 23, Issue 2, pp. 513 - 517
A series of carbazole or phenoxazine containing alkoxyindole-3-acetic acid analogs were prepared as PPAR[gamma]/[d] agonists and their transactivation... 
Carbazole
Journal Article
Chemical Communications : Chem Comm, ISSN 1359-7345, 01/2019, Volume 55, Issue 91, pp. 13749 - 13752
Highly π-extended hetero-cyclic/aromatic skeletons are of great importance as they can be utilized in many organic material based technologies. Therefore,... 
Carbazoles | Oxidation
Journal Article
Journal of Chemical Research, ISSN 1747-5198, 01/2011, Volume 35, Issue 1, pp. 1 - 3
  Reaction of pyrrole, indole or carbazole with dialkyl acetylenedicarboxylates catalysed by N-methylimidazole provides a simple and efficient route for the... 
Carbazoles
Journal Article
Journal of Chemical Research, ISSN 1747-5198, 01/2011, Volume 35, Issue 1, pp. 53 - 59
  2-Furylmethylene-2,3,4,9-tetrahydrocarbazol-1-ones were obtained from the mixed aldol condensation of 2,3,4,9-tetrahydrocarbazole-1-ones and... 
Carbazoles
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2012, Volume 109, Issue 42, pp. 17010 - 17015
Journal Article
Science, ISSN 0036-8075, 8/2012, Volume 337, Issue 6098, pp. 1094 - 1097
Impairment of the circadian clock has been associated with numerous disorders, including metabolic disease. Although small molecules that modulate clock... 
Molecules | Carbazoles | Hepatocytes | HEK293 cells | Chronobiology | Genes | REPORTS | Cell lines | Luminescence | Fibroblasts | Resins | HOMEOSTASIS | CHEMICAL BIOLOGY | METABOLISM | RHYTHMS | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | PERIOD | DEGRADATION | MAMMALIAN CIRCADIAN CLOCK | OSCILLATIONS | REVEALS | Glucose-6-Phosphatase - genetics | Carbazoles - chemistry | Gluconeogenesis - drug effects | Humans | Molecular Sequence Data | Hepatocytes - metabolism | Phosphoenolpyruvate Carboxykinase (GTP) - genetics | Proteolysis - drug effects | Sulfonamides - isolation & purification | Liver - drug effects | HEK293 Cells | Cryptochromes - agonists | Hepatocytes - drug effects | Cryptochromes - metabolism | Carbazoles - isolation & purification | Amino Acid Sequence | Circadian Clocks - drug effects | Sulfonamides - chemistry | Liver - metabolism | Sulfonamides - pharmacology | Animals | Gluconeogenesis - genetics | Small Molecule Libraries | Protein Stability - drug effects | Cell Line, Tumor | Liver - cytology | Mice | Carbazoles - pharmacology | 3T3 Cells | Circadian rhythms | Ubiquitin | Molecular dynamics | Physiological aspects | Research | Proteins | Biochemistry | Circadian rhythm | Molecular biology | Biotechnology | Biomedical materials | Medical services | Disorders | Derivatives | Chemical compounds | Culture | Biological clocks
Journal Article
Chemical Communications : Chem Comm, ISSN 1359-7345, 01/2017, Volume 53, Issue 97, pp. 13039 - 13042
We report the C4-selective C–H alkylation of carbazole derivatives furnished with a pyrimidine directing group at N9. This was realized using ruthenium... 
Carbazoles | Activation | Ruthenium | Alkylation
Journal Article
Archives of Toxicology, ISSN 0340-5761, 10/2017, Volume 91, Issue 10, pp. 3365 - 3372
The maintenance of cellular homeostasis is a complex process that is governed by the receipt of prototypical growth and death signals. The endogenous functions... 
Biomedicine, general | Cell growth | Biomedicine | Environmental Health | Occupational Medicine/Industrial Medicine | 6-Formylindolo[3,2- b ]carbazole (FICZ) | Pharmacology/Toxicology | Mitochondrial-dependent pathway | Apoptosis | 6-Formylindolo[3,2-b]carbazole (FICZ) | OXIDATIVE STRESS | AH RECEPTOR | HEPATOMA-CELLS | 6-Formylindolo[3,2-b] carbazole ( FICZ) | CYTOCHROME-C | 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD)-INDUCED IMMUNOTOXICITY | CYCLE CONTROL | IMMUNE-SYSTEM | RETINOBLASTOMA PROTEIN | ARYL-HYDROCARBON RECEPTOR | TOXICOLOGY | T-CELLS | Cell Survival - drug effects | Reactive Oxygen Species - metabolism | Oxidative Stress | Apoptosis - drug effects | Glutathione - metabolism | Cytochromes c - metabolism | Humans | Carbazoles - administration & dosage | Cytochrome P-450 CYP1A1 - antagonists & inhibitors | Cytochrome P-450 CYP1A1 - metabolism | Membrane Potential, Mitochondrial - drug effects | Hep G2 Cells | Dose-Response Relationship, Drug | Cell Proliferation - drug effects | Flavonoids - pharmacology | Carbazoles - pharmacology | Carbazoles - metabolism | Flavonoids | Flavones | Growth | Bioflavonoids | Analysis | Cytochrome P-450 | Cytochrome | Oxidative stress | Enzyme activity | Low concentrations | Toxicity | Cytochrome P450 | Homeostasis | Hepatoma | Carbazole | Mitochondria | Enzymatic activity | Aromatic compounds | Cell death | Trace levels | Biocompatibility | Kinetics | Viability | Growth kinetics
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
RESISTANT | MEDICINE, GENERAL & INTERNAL | MODELS | ANTITUMOR-ACTIVITY | INHIBITOR ALECTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article